REG - Deutsche Bank AG FF - Post Stabilisation Notice - Fresenius Medical Care

Fresenius Medical Care AGAnnouncement

22/06/2020 18:05

RNS Number : 7068Q
  
Deutsche Bank AG, Frankfurt
  
22 June 2020
  
 

22-Jun-20
 
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in
which such distribution would be unlawful.
 
Fresenius Medical Care AG & Co KGaA


Post-stabilisation Period Announcement
 
Further to the pre-stabilisation period announcement dated 19/05/201 Deutsche Bank AG (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.
 
The Securities:
 
Issuer:                                                                             Fresenius Medical Care AG & Co KGaA
 
Guarantor (if any):                                                        Fresenius Medical Care Holdings, Inc.
 
Aggregate nominal amount:                                       EUR 1.25 Billion
 
Description:                                                                   Fresenius Medical Care 6yr & 10yr EUR1.25bn dual-tranche
 
Stabilisation Manager(s):                                            Commerzbank, Deutsche Bank, Mizuho, Societe       Generale                           
 
Offer Price:                                                                     99.405% / 99.742%
 
 
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
STAEASKAASNEEFA